• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treatment effects for which shift or binary analyses are advantageous in acute stroke trials.在急性中风试验中,移位或二元分析具有优势的治疗效果。
Neurology. 2009 Apr 14;72(15):1310-5. doi: 10.1212/01.wnl.0000341308.73506.b7. Epub 2008 Dec 17.
2
Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.急性卒中试验中新型终点分析技术及解读整个结局量表范围内的变化
Stroke. 2007 Nov;38(11):3055-62. doi: 10.1161/STROKEAHA.107.488536. Epub 2007 Oct 4.
3
Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices.急性脑卒中治疗试验的最佳终点:评估药物和器械治疗效果的最佳方法。
Stroke. 2011 Aug;42(8):2356-62. doi: 10.1161/STROKEAHA.111.619122. Epub 2011 Jun 30.
4
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
5
Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale.使用具有不可观测基线的分段多状态马尔可夫模型对有序功能结局的治疗效果:以改良Rankin量表为例
J Biopharm Stat. 2019;29(1):82-97. doi: 10.1080/10543406.2018.1489404. Epub 2018 Jul 9.
6
Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials.在国立神经疾病与中风研究所(NINDS)和欧洲急性卒中协作研究II(ECASS-II)试验中,改良Rankin量表结局评分的移位分析与二分法比较
Stroke. 2007 Dec;38(12):3205-12. doi: 10.1161/STROKEAHA.107.489351. Epub 2007 Nov 1.
7
Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.急性中风临床试验设计中的结果分析:医生的态度与选择。
Cerebrovasc Dis. 2008;26(2):156-62. doi: 10.1159/000139663. Epub 2008 Jun 17.
8
Quantification of errors in ordinal outcome scales using shannon entropy: effect on sample size calculations.使用香农熵对有序结局量表中的误差进行量化:对样本量计算的影响。
PLoS One. 2013 Jul 5;8(7):e67754. doi: 10.1371/journal.pone.0067754. Print 2013.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy.将神经保护临床试验针对有可能从治疗中获益的缺血性中风患者。
Stroke. 2004 Sep;35(9):2111-6. doi: 10.1161/01.STR.0000136556.34438.b3. Epub 2004 Jul 8.

引用本文的文献

1
Effectiveness of intravenous thrombolysis in patients with large-vessel occlusion receiving endovascular treatment in Korea.韩国接受血管内治疗的大血管闭塞患者静脉溶栓的有效性。
Acute Crit Care. 2025 Apr 11;40(2):282-92. doi: 10.4266/acc.004248.
2
Clinical Impact of Standardized Interpretation and Reporting of Multimodality Neuromonitoring Data.多模态神经监测数据的标准化解读和报告的临床影响。
Crit Care Explor. 2024 Aug 9;6(8):e1139. doi: 10.1097/CCE.0000000000001139. eCollection 2024 Aug 1.
3
Association of Renal Impairment with Clinical Outcomes Following Endovascular Therapy in Acute Basilar Artery Occlusion.急性基底动脉闭塞血管内治疗后肾功能不全与临床结局的关系。
Clin Interv Aging. 2024 Jun 6;19:1017-1028. doi: 10.2147/CIA.S462638. eCollection 2024.
4
Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure.优化血管预防试验分析:对TARDIS试验的重新评估,这是首个采用有序主要结局指标的预防试验。
Contemp Clin Trials Commun. 2023 Jul 5;35:101186. doi: 10.1016/j.conctc.2023.101186. eCollection 2023 Oct.
5
Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study.脑活素作为再灌注治疗的早期附加治疗:缺血性卒中后出血性转化的风险(CEREHETIS),一项前瞻性、随机、多中心的初步研究。
BMC Neurol. 2023 Mar 27;23(1):121. doi: 10.1186/s12883-023-03159-w.
6
Outcome Prediction of Spontaneous Supratentorial Intracerebral Hemorrhage after Surgical Treatment Based on Non-Contrast Computed Tomography: A Multicenter Study.基于非增强计算机断层扫描的自发性幕上脑出血手术治疗后的结局预测:一项多中心研究
J Clin Med. 2023 Feb 16;12(4):1580. doi: 10.3390/jcm12041580.
7
Key design elements of successful acute ischemic stroke treatment trials.成功的急性缺血性中风治疗试验的关键设计要素。
Neurol Res Pract. 2023 Jan 5;5(1):1. doi: 10.1186/s42466-022-00221-9.
8
Diabetes: Chronic Metformin Treatment and Outcome Following Acute Stroke.糖尿病:急性中风后的慢性二甲双胍治疗及预后
Front Neurol. 2022 Apr 26;13:849607. doi: 10.3389/fneur.2022.849607. eCollection 2022.
9
Risk factors for poor outcomes of spontaneous supratentorial cerebral hemorrhage after surgery.手术治疗后自发性幕上脑出血不良预后的风险因素。
J Neurol. 2022 Jun;269(6):3015-3025. doi: 10.1007/s00415-021-10888-w. Epub 2021 Nov 17.
10
Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change.预测取栓后 90 天的结局:基线校正 24 小时 NIHSS 比 NIHSS 评分变化更有价值。
Stroke. 2021 Aug;52(8):2547-2553. doi: 10.1161/STROKEAHA.120.032487. Epub 2021 May 18.

本文引用的文献

1
Consequences of dichotomization.二分法的后果。
Pharm Stat. 2009 Jan-Mar;8(1):50-61. doi: 10.1002/pst.331.
2
Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials.在国立神经疾病与中风研究所(NINDS)和欧洲急性卒中协作研究II(ECASS-II)试验中,改良Rankin量表结局评分的移位分析与二分法比较
Stroke. 2007 Dec;38(12):3205-12. doi: 10.1161/STROKEAHA.107.489351. Epub 2007 Nov 1.
3
Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.急性卒中试验中新型终点分析技术及解读整个结局量表范围内的变化
Stroke. 2007 Nov;38(11):3055-62. doi: 10.1161/STROKEAHA.107.488536. Epub 2007 Oct 4.
4
Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan.大脑中动脉卒中6小时内动脉内输注尿激酶的随机试验:日本大脑中动脉栓塞局部纤溶干预试验(MELT)
Stroke. 2007 Oct;38(10):2633-9. doi: 10.1161/STROKEAHA.107.488551. Epub 2007 Aug 16.
5
Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials.我们能否改进中风试验的统计分析?中风试验功能结局的统计重新分析。
Stroke. 2007 Jun;38(6):1911-5. doi: 10.1161/STROKEAHA.106.474080. Epub 2007 Apr 26.
6
Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).缺血性中风的红外激光疗法:一种新的治疗策略:神经治疗有效性和安全性试验-1(NEST-1)的结果
Stroke. 2007 Jun;38(6):1843-9. doi: 10.1161/STROKEAHA.106.478230. Epub 2007 Apr 26.
7
NXY-059 for acute ischemic stroke.NXY - 059用于急性缺血性卒中。
N Engl J Med. 2006 Feb 9;354(6):588-600. doi: 10.1056/NEJMoa052980.
8
Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36.以健康相关生活质量为结局的研究的样本量和效能估计:使用SF-36对四种方法的比较
Health Qual Life Outcomes. 2004 May 25;2:26. doi: 10.1186/1477-7525-2-26.
9
Cerebral vascular accidents in patients over the age of 60. II. Prognosis.60岁以上患者的脑血管意外。II. 预后。
Scott Med J. 1957 May;2(5):200-15. doi: 10.1177/003693305700200504.
10
Choice of test for comparing two groups, with particular application to skewed outcomes.比较两组的检验方法选择,尤其适用于偏态结果。
Stat Med. 2003 Apr 30;22(8):1205-15. doi: 10.1002/sim.1420.

在急性中风试验中,移位或二元分析具有优势的治疗效果。

Treatment effects for which shift or binary analyses are advantageous in acute stroke trials.

作者信息

Saver Jeffrey L, Gornbein Jeffrey

机构信息

UCLA Stroke Center, 710 Westwood Plaza, Los Angeles, CA 90095, USA.

出版信息

Neurology. 2009 Apr 14;72(15):1310-5. doi: 10.1212/01.wnl.0000341308.73506.b7. Epub 2008 Dec 17.

DOI:10.1212/01.wnl.0000341308.73506.b7
PMID:19092107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2677490/
Abstract

BACKGROUND

In acute stroke trials, functional outcome may be analyzed by dichotomizing ordinal outcome scales or by evaluating the entire scale range (shift analysis). The conditions under which shift or binary analysis will be more efficient have not been previously well delineated.

METHODS

Model randomized clinical trials employing the modified Rankin Scale of global handicap were constructed to reflect 1) mild benefits experienced across all ranges of stroke severity (neuroprotective effect), 2) substantial benefits across all ranges of stroke severity (early recanalization effect), 3) substantial benefits across wide range of stroke severity but with limited ability to achieve fully normal outcome (late recanalization effect), 4) benefits clustered at unexpected health state transitions.

RESULTS

In neuroprotective models, shift analysis was the most efficient technique in detecting a treatment effect. In the early recanalization models, dichotomization at excellent outcome and shift analysis were of comparable efficiency, both superior to dichotomization at good outcome. In the late recanalization models, dichotomization at good outcome performed best, shift analysis less well, and dichotomization at excellent outcome poorly. In the unexpected benefits model, shift analysis substantially outperformed dichotomization analyses. These patterns held among the seven actual acute trials reporting full range Rankin outcomes and showing treatment benefit identified in the literature.

CONCLUSIONS

The pattern of treatment effect of the intervention determines whether shift analysis or simple dichotomized analysis will be more efficient. Shift analysis is especially advantageous when treatments confer a relatively uniform, mild benefit to patients over a wide range of stroke severities or confer benefits at unexpected but clinically important health state transitions.

摘要

背景

在急性中风试验中,功能结局可通过对有序结局量表进行二分法分析或评估整个量表范围(移位分析)来进行分析。移位分析或二分法分析在何种情况下效率更高,此前尚未得到很好的界定。

方法

构建采用改良Rankin全球残疾量表的模型随机临床试验,以反映1)在所有中风严重程度范围内均有轻度获益(神经保护作用),2)在所有中风严重程度范围内均有显著获益(早期再通作用),3)在广泛的中风严重程度范围内有显著获益,但实现完全正常结局的能力有限(晚期再通作用),4)获益集中在意外的健康状态转变。

结果

在神经保护模型中,移位分析是检测治疗效果最有效的技术。在早期再通模型中,将良好结局进行二分法分析和移位分析的效率相当,均优于将优秀结局进行二分法分析。在晚期再通模型中,将良好结局进行二分法分析效果最佳,移位分析次之,将优秀结局进行二分法分析效果最差。在意外获益模型中,移位分析明显优于二分法分析。这些模式在七项实际的急性试验中也成立,这些试验报告了完整范围的Rankin结局,并显示出文献中确定的治疗获益。

结论

干预措施的治疗效果模式决定了移位分析或简单二分法分析哪种更有效。当治疗在广泛的中风严重程度范围内为患者带来相对一致、轻度的获益,或在意外但具有临床重要性的健康状态转变时带来获益时,移位分析尤其具有优势。